After a ‘rigorous multi-state search’, Elanco Animal Health has revealed Indiana as its base for future global operations, anchored by a new headquarters in Indianapolis.
The move represents another step in Elanco’s plan ‘to capture economic value through global footprint consolidation’ after its August acquisition of Bayer’s animal health business.
The incentive package offered by the State of Indiana and the City of Indianapolis includes a 45-acre former industrial site in the southwest corner of downtown Indianapolis on the White River, with a restricted option for an additional 20 acres.
The package also includes tax credits for retention of more than 1,600 existing jobs in Indiana, as well as the addition of 570-plus Indiana jobs over the next 10 years. It also allows for training and relocation grants as well as redevelopment tax credits as the company relocates to the $100m campus to be built on the Indianapolis site.
